In 2012, Yadav et al. demonstrated that Gatifloxacin could induce cell cycle arrest at the S and G2 phases via the activation of p21 and p53 in the pancreatic cancer cell line, a finding that was similar to our result [49]. This evidence concerns the gene TP53 and pancreatic neoplasm.